Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,905 | -12,585 | -18,141 | -9,855 | -9,437 |
| Depreciation Amortization | 23 | 11 | 40 | 29 | 19 |
| Accounts receivable | N/A | N/A | N/A | N/A | -2,452 |
| Accounts payable and accrued liabilities | 92 | -1,984 | -672 | -3,019 | N/A |
| Other Working Capital | -78 | -1,811 | -1,450 | -3,471 | -3,299 |
| Other Operating Activity | -999 | 7,200 | -4,401 | -1,814 | 2,037 |
| Operating Cash Flow | $-13,867 | $-9,169 | $-24,625 | $-18,131 | $-13,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,022 | N/A | -10,022 | -45,101 | -46,120 |
| PPE Investments | -37 | -6 | -55 | -48 | -48 |
| Other Investing Activity | 0 | 0 | 10 | 0 | 0 |
| Investing Cash Flow | $9,985 | $-6 | $-10,067 | $-45,149 | $-46,168 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -98 | -6 | -130 | -115 | 43 |
| Beginning Cash Position | 34,099 | 34,099 | 68,920 | 68,920 | 68,920 |
| End Cash Position | 30,119 | 24,919 | 34,099 | 5,525 | 9,663 |
| Net Cash Flow | $-3,980 | $-9,180 | $-34,821 | $-63,395 | $-59,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,867 | -9,169 | -24,625 | -18,131 | -13,132 |
| Capital Expenditure | -37 | -6 | -55 | -48 | -48 |
| Free Cash Flow | -13,904 | -9,174 | -24,679 | -18,179 | -13,180 |